Nucleic acid sequences and chemical reagents for medical purposes, namely, retroviral vectors and retroviral vector manufacturing preparations; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of diseases, namely, infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases; pharmaceutical preparations for the treatment of viral infections such as from MERS, SARS-Cov-1, COVID-19/SARS-CoV-2 virus
Pharmaceuticals